Cargando…
Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives
BACKGROUND: Survival analysis is the most appropriate method of analysis for time-to-event data. The classical accelerated failure-time model is a more powerful and interpretable model than the Cox proportional hazards model, provided that model imposed distribution and homoscedasticity assumptions...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165794/ https://www.ncbi.nlm.nih.gov/pubmed/34059125 http://dx.doi.org/10.1186/s13690-021-00617-0 |
_version_ | 1783701384967749632 |
---|---|
author | Mustefa, Yesuf Abdela Chen, Ding-Geng |
author_facet | Mustefa, Yesuf Abdela Chen, Ding-Geng |
author_sort | Mustefa, Yesuf Abdela |
collection | PubMed |
description | BACKGROUND: Survival analysis is the most appropriate method of analysis for time-to-event data. The classical accelerated failure-time model is a more powerful and interpretable model than the Cox proportional hazards model, provided that model imposed distribution and homoscedasticity assumptions satisfied. However, most of the real data are heteroscedastic which violates the fundamental assumption and consequently, the statistical inference could be erroneous in accelerated failure-time modeling. The weighted least-squares estimation for the accelerated failure-time model is an efficient semi-parametric approach for time-to-event data without the homoscedasticity assumption, which is developed recently and not often utilized for real data analysis. Thus, this study was conducted to ascertain the better performance of the weighted least-squares estimation method over the classical methods. METHODS: We analyzed a REAL dataset on Antiretroviral Therapy patients we recently collected. We compared the results from classical methods of estimation for the accelerated failure-time model with the results revealed from the weighted least-squares estimation. RESULTS: We found that the data are heteroscedastic and indicated that the weighted least-square method should be used to analyze this data. The weighted least-squares estimation revealed more accurate, and efficient estimates of covariates effect since its confidence intervals were shorter and it identified more significant covariates. Accordingly, the survival of HIV positives was found to be significantly linked with age, weight, functional status, CD4 (Cluster of Differentiation agent 4 glycoproteins), and clinical stages. CONCLUSIONS: The weighted least-squares estimation performed the best in providing more significant effects and precise estimates than the classical accelerated failure-time methods of estimation if data are heteroscedastic. Thus, we recommend future researchers should utilize weighted least-squares estimation rather than the classical methods when the homoscedasticity assumption is violated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00617-0. |
format | Online Article Text |
id | pubmed-8165794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81657942021-06-01 Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives Mustefa, Yesuf Abdela Chen, Ding-Geng Arch Public Health Research BACKGROUND: Survival analysis is the most appropriate method of analysis for time-to-event data. The classical accelerated failure-time model is a more powerful and interpretable model than the Cox proportional hazards model, provided that model imposed distribution and homoscedasticity assumptions satisfied. However, most of the real data are heteroscedastic which violates the fundamental assumption and consequently, the statistical inference could be erroneous in accelerated failure-time modeling. The weighted least-squares estimation for the accelerated failure-time model is an efficient semi-parametric approach for time-to-event data without the homoscedasticity assumption, which is developed recently and not often utilized for real data analysis. Thus, this study was conducted to ascertain the better performance of the weighted least-squares estimation method over the classical methods. METHODS: We analyzed a REAL dataset on Antiretroviral Therapy patients we recently collected. We compared the results from classical methods of estimation for the accelerated failure-time model with the results revealed from the weighted least-squares estimation. RESULTS: We found that the data are heteroscedastic and indicated that the weighted least-square method should be used to analyze this data. The weighted least-squares estimation revealed more accurate, and efficient estimates of covariates effect since its confidence intervals were shorter and it identified more significant covariates. Accordingly, the survival of HIV positives was found to be significantly linked with age, weight, functional status, CD4 (Cluster of Differentiation agent 4 glycoproteins), and clinical stages. CONCLUSIONS: The weighted least-squares estimation performed the best in providing more significant effects and precise estimates than the classical accelerated failure-time methods of estimation if data are heteroscedastic. Thus, we recommend future researchers should utilize weighted least-squares estimation rather than the classical methods when the homoscedasticity assumption is violated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00617-0. BioMed Central 2021-05-31 /pmc/articles/PMC8165794/ /pubmed/34059125 http://dx.doi.org/10.1186/s13690-021-00617-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mustefa, Yesuf Abdela Chen, Ding-Geng Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives |
title | Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives |
title_full | Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives |
title_fullStr | Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives |
title_full_unstemmed | Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives |
title_short | Accelerated failure-time model with weighted least-squares estimation: application on survival of HIV positives |
title_sort | accelerated failure-time model with weighted least-squares estimation: application on survival of hiv positives |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165794/ https://www.ncbi.nlm.nih.gov/pubmed/34059125 http://dx.doi.org/10.1186/s13690-021-00617-0 |
work_keys_str_mv | AT mustefayesufabdela acceleratedfailuretimemodelwithweightedleastsquaresestimationapplicationonsurvivalofhivpositives AT chendinggeng acceleratedfailuretimemodelwithweightedleastsquaresestimationapplicationonsurvivalofhivpositives |